RBC Capital Initiates Coverage On Inspire Medical Systems with Outperform Rating, Announces Price Target of $285
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh initiates coverage on Inspire Medical Systems (NYSE:INSP) with an Outperform rating and a price target of $285.
April 19, 2024 | 9:53 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital has initiated coverage on Inspire Medical Systems with an Outperform rating and set a price target of $285.
The initiation of coverage by RBC Capital with an Outperform rating and a high price target suggests a strong positive outlook for Inspire Medical Systems. This endorsement from a reputable analyst could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100